1241.20.00031 Boehringer Ingelheim Investigational Site

New York, New York

0 studies enrolling now · 1 studies all time

What they study most

Hepatitis C, Chronic

Studies at this site

• IFN-free Combination Therapy in HCV-infected Patients Treatment-naive:HCVerso1 — Completed